Chimenti S - Search Results

1

What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice.

Talamonti M, Galluzzo M, Bianchi L, Boca AN, Costanzo A, Chimenti S. Talamonti M, et al. Among authors: chimenti s. Dermatology. 2014;229(4):324-32. doi: 10.1159/000365077. Epub 2014 Nov 15. Dermatology. 2014. PMID: 25402662

2

Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.

Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, Bianchi L, Chimenti S. Papoutsaki M, et al. Among authors: chimenti ms, chimenti s. J Am Acad Dermatol. 2007 Aug;57(2):269-75. doi: 10.1016/j.jaad.2006.12.003. Epub 2007 Jun 18. J Am Acad Dermatol. 2007. PMID: 17574299 Clinical Trial.

3

Long-term efficacy of adalimumab in generalized pustular psoriasis.

Zangrilli A, Papoutsaki M, Talamonti M, Chimenti S. Zangrilli A, et al. Among authors: chimenti s. J Dermatolog Treat. 2008;19(3):185-7. doi: 10.1080/09546630701759587. J Dermatolog Treat. 2008. PMID: 18569276 Free article.

4

Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy.

Costanzo A, Talamonti M, Spallone G, Botti E, Chimenti MS, Papoutsaki M, Chimenti S. Costanzo A, et al. Among authors: chimenti ms, chimenti s. Dermatology. 2009;218(2):146-50. doi: 10.1159/000168086. Epub 2008 Oct 30. Dermatology. 2009. PMID: 18971577

5

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.

Mazzotta A, Esposito M, Costanzo A, Chimenti S. Mazzotta A, et al. Among authors: chimenti s. Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19658444 Clinical Trial.

6

Efalizumab.

Talamonti M, Spallone G, Di Stefani A, Costanzo A, Chimenti S. Talamonti M, et al. Among authors: chimenti s. Expert Opin Drug Saf. 2011 Mar;10(2):239-51. doi: 10.1517/14740338.2011.524925. Epub 2011 Jan 10. Expert Opin Drug Saf. 2011. PMID: 21214420 Review.

7

Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome.

Talamonti M, Galluzzo M, Chiricozzi A, Teoli M, Bavetta M, Costanzo A, Chimenti S. Talamonti M, et al. Among authors: chimenti s. J Drugs Dermatol. 2012 Aug;11(8):1000-2. J Drugs Dermatol. 2012. PMID: 22859249

8

Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

Di Stefani A, Galluzzo M, Talamonti M, Chiricozzi A, Costanzo A, Chimenti S. Di Stefani A, et al. Among authors: chimenti s. J Dermatol Case Rep. 2013 Mar 30;7(1):5-9. doi: 10.3315/jdcr.2013.1127. Print 2013 Mar 30. J Dermatol Case Rep. 2013. PMID: 23580907 Free PMC article.

9

Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.

Saraceno R, Talamonti M, Galluzzo M, Chiricozzi A, Costanzo A, Chimenti S. Saraceno R, et al. Among authors: chimenti s. Case Rep Dermatol. 2013 Sep 26;5(3):254-9. doi: 10.1159/000348645. eCollection 2013. Case Rep Dermatol. 2013. PMID: 24163658 Free PMC article.

10

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.

Galluzzo M, Boca AN, Botti E, Potenza C, Malara G, Malagoli P, Vesa S, Chimenti S, Buzoianu AD, Talamonti M, Costanzo A. Galluzzo M, et al. Among authors: chimenti s. Dermatology. 2016;232(2):230-6. doi: 10.1159/000441719. Epub 2015 Dec 18. Dermatology. 2016. PMID: 26678060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters